Khan et al. [99] suggested the EV survivin content as a promising biomarker for patients with high PSA with or without tumors, reporting that survivin in circulating EV shows higher expression in patients with PC compared to BPH and healthy controls. Here, BIRC5 is linked to benign prostatic hyperplasia.